| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/03/2011 | US20110053911 Tricyclic derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 03/03/2011 | US20110053909 Compounds - 801 |
| 03/03/2011 | US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 03/03/2011 | US20110053905 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053904 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | US20110053896 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 03/03/2011 | US20110053893 Compounds and compositions as tlr activity modulators |
| 03/03/2011 | US20110053877 Nimesulide and muscle relaxant combinations thereof |
| 03/03/2011 | US20110053876 macrolides and their use |
| 03/03/2011 | US20110053873 Hsp90 inhibitors |
| 03/03/2011 | US20110053864 Compositions and methods for modulation of cell migration |
| 03/03/2011 | US20110053853 Use of copolymer 1 for treatment of muscular dystrophy |
| 03/03/2011 | US20110053849 Regulation of litaf modulated cytokine production by a novel p53 short peptide |
| 03/03/2011 | US20110053845 Localized vaginal delivery without detrimental blood levels |
| 03/03/2011 | US20110053833 Synthetic peptides and their use |
| 03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
| 03/03/2011 | US20110052739 Active Ingredient That Stimulates the Proliferation and/or Activity of Fibroblasts |
| 03/03/2011 | US20110052738 Topical pain formulation |
| 03/03/2011 | US20110052729 Pharmaceutical or nutraceutical composition |
| 03/03/2011 | US20110052723 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 03/03/2011 | US20110052703 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052685 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| 03/03/2011 | US20110052679 Solid naproxen concentrates and related dosage forms |
| 03/03/2011 | US20110052677 Modulation of srpx2-mediated angiogenesis |
| 03/03/2011 | US20110052676 Composition For Delaying Cellular Senescence |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052613 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| 03/03/2011 | US20110052610 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 03/03/2011 | US20110052609 Magnetic transducers |
| 03/03/2011 | US20110052606 Humanized Anti-Human NKG2A Monoclonal Antibody |
| 03/03/2011 | US20110052596 Antibodies to il-17a |
| 03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
| 03/03/2011 | US20110052568 Tablet comprising natural allicin and method for producing the same |
| 03/03/2011 | US20110052535 Compositions for treating an inflammatory autoimmune condition |
| 03/03/2011 | US20110052522 Cosmetics comprising cistus plant extracts |
| 03/03/2011 | US20110052501 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 03/03/2011 | DE102009037089A1 Zusammensetzung mit Stämmen von Lactobazillus fermentum Composition with Lactobacillus fermentum strains of |
| 03/03/2011 | CA2771992A1 Kinase inhibitors |
| 03/03/2011 | CA2771871A1 Pharmaceutical compositions comprising prednisolone metasulfobenzoate and 5-asa for treating ibd |
| 03/03/2011 | CA2770866A1 Cannabinoid receptor modulators |
| 03/03/2011 | CA2767770A1 Pyrrolidine derivatives as nk3 receptor antagonists |
| 03/02/2011 | EP2289970A1 Biocompatible polymers, their process of manufacture and compositions containing them |
| 03/02/2011 | EP2289941A2 Administration of agents for the treatment of inflammation |
| 03/02/2011 | EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289545A2 Supplemented OMV vaccine against meningococcus |
| 03/02/2011 | EP2289509A2 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 03/02/2011 | EP2289499A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 03/02/2011 | EP2288621A2 Il-23 receptor antagonists and uses thereof |
| 03/02/2011 | EP2288361A1 Cistus extract containing enriched secondary plant ingredients |
| 03/02/2011 | EP2288356A1 Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation |
| 03/02/2011 | EP2288353A2 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation |
| 03/02/2011 | EP2288352A2 Clonidine formulation in a polyorthoester carrier |
| 03/02/2011 | EP2066685B1 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| 03/02/2011 | EP1981862B1 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 03/02/2011 | EP1638552B1 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer |
| 03/02/2011 | EP1383761B1 Phenyl- and pyridyl-piperidines with tnf activity |
| 03/02/2011 | EP1100824B1 Compounds with growth hormone releasing properties |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/02/2011 | CN101982471A Technological process for extracting aucubin from fruits of eucommia ulmoides oliver |
| 03/02/2011 | CN101982458A 3-amino-3-arylpropionic acid and preparation method thereof |
| 03/02/2011 | CN101982198A Perfusion medicinal oil for treating hysteritis of cow and preparation method thereof |
| 03/02/2011 | CN101982195A Medicine for treating rheumatoid arthritis pain and preparation method thereof |
| 03/02/2011 | CN101982186A Application of velvet bean extractive on preparing anti-inflammatory analgesic drug |
| 03/02/2011 | CN101982168A Quercetin nano-micelle preparation and preparation method thereof |
| 03/02/2011 | CN101543488B A medicine containing caffeic acid 3,4-dihydroxyl phenethyl ester and its uses |
| 03/02/2011 | CN101455783B Rheumatism pain-alleviating soap and preparation method thereof |
| 03/02/2011 | CN101406532B Medicament for mainly curing rheumatism |
| 03/02/2011 | CN101084889B Ginkgolide freezing-dried powder injection and preparation method thereof |
| 03/02/2011 | CN101073365B Lily health-care heat-clearing tea and its production |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897644 Antiinflammatory agents; analgesics |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | CA2677068A1 Nucleic acid compounds for inhibiting gene expression and uses thereof |
| 03/01/2011 | CA2411660C Enzyme-cleavable prodrug compounds |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 02/24/2011 | WO2011022449A1 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |
| 02/24/2011 | WO2011022348A1 Ethylene diamine modulators of fatty acid amide hydrolase |
| 02/24/2011 | WO2011022334A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
| 02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
| 02/24/2011 | WO2011021833A2 Composition for preventing or treating inflammation |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021203A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | WO2011020853A1 Compositions containing mixtures of fermentable fibers |
| 02/24/2011 | WO2010086860A3 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them |
| 02/24/2011 | WO2010009892A8 Compositions for the treatment of pain and/or inflamation |
| 02/24/2011 | WO2009153434A8 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response |
| 02/24/2011 | US20110046722 Oxazinyl isoflavonoid compounds, medicaments and use |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046546 Methods for treating headaches |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046235 Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee |
| 02/24/2011 | US20110046230 Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof |
| 02/24/2011 | US20110046225 Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide |
| 02/24/2011 | US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| 02/24/2011 | US20110046197 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |